TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004
TCL Archive NCI And SPORE PIs Discussing Potential Changes To Grant Program Guidelines. September 19, 2008
TCL Archive Von Eschenbach Says He Will Step Down as NCI Director; No Acting Director Has Been Named. March 24, 2006
